Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C12H21NO8S |
Molecular Weight | 339.362 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
InChI
InChIKey=KJADKKWYZYXHBB-XBWDGYHZSA-N
InChI=1S/C12H21NO8S/c1-10(2)18-7-5-16-12(6-17-22(13,14)15)9(8(7)19-10)20-11(3,4)21-12/h7-9H,5-6H2,1-4H3,(H2,13,14,15)/t7-,8-,9+,12+/m1/s1
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C264
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
||
|
WHO-ATC |
N03AX11
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
||
|
FDA ORPHAN DRUG |
283909
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
||
|
NDF-RT |
N0000008486
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
||
|
NDF-RT |
N0000175753
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
||
|
WHO-VATC |
QN03AX11
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
||
|
LIVERTOX |
NBK548632
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
||
|
FDA ORPHAN DRUG |
70792
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
QSIVA (REFUSED: OBESITY)
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
N0000182140
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | Cytochrome P450 2C19 Inhibitors [MoA] | ||
|
97240-79-4
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | |||
|
Y-25
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | |||
|
7531
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | |||
|
2706
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | |||
|
0H73WJJ391
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | |||
|
TOPIRAMATE
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | |||
|
Topiramate
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | |||
|
63631
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | |||
|
CHEMBL220492
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | |||
|
1672206
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | |||
|
m10976
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000092536
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | |||
|
0H73WJJ391
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | |||
|
6849
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | |||
|
N0000185506
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | Cytochrome P450 3A4 Inducers [MoA] | ||
|
6099
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | |||
|
DTXSID8023688
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | |||
|
5284627
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | |||
|
C47764
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | |||
|
C052342
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | |||
|
38404
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | RxNorm | ||
|
SUB11190MIG
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY | |||
|
DB00273
Created by
admin on Fri Dec 15 15:06:17 UTC 2023 , Edited by admin on Fri Dec 15 15:06:17 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
SALT/SOLVATE (PARENT)